Showing results (731-740 of 1,577) with videos related to

Sort By:
Pageof 158
American Journal of Clinical Dermatology|May 20, 2020
Treatment Goals in Psoriasis: Which Outcomes Matter Most?Steven A Svoboda, Rima I Ghamrawi, Dorellie A Owusu, et al.
American Journal of Clinical Dermatology|May 6, 2021
Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported OutcomesJonathan I Silverberg, Jacob P Thyssen, Eric L Simpson, et al.
American Journal of Clinical Dermatology|June 13, 2020
Dermatologic Laser Side Effects and Complications: Prevention and ManagementTina S Alster, Monica K Li
American Journal of Clinical Dermatology|August 14, 2022
Management of Coexisting Bullous Pemphigoid and Psoriasis: A ReviewChang-Yu Hsieh, Tsen-Fang Tsai
American Journal of Clinical Dermatology|December 1, 2025
Cardiovascular Imaging in Psoriasis: A Critical Review of Current Evidence, Techniques, and Therapeutic ImplicationsJacopo Tartaglia, Monica Ponzano, Roberto Mazzetto, et al.
American Journal of Clinical Dermatology|January 24, 2026
Cutaneous Manifestations of Emerging Arbovirus Infections Including West Nile, Dengue, Zika, Chikungunya, Usutu, and Toscana Viruses: A Clinical Overview for DermatologistsFranco Rongioletti, Francesco Drago
American Journal of Clinical Dermatology|January 14, 2026
Switching from Dupilumab to Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis After Inadequate Response to Dupilumab: Efficacy and Safety Results from Period 2 of Phase 3b/4 Study (LEVEL UP)Christopher G Bunick, Nina Magnolo, Angela Moore, et al.
American Journal of Clinical Dermatology|June 30, 2025
Alopecia in Children with Cancer: A Review from Pathophysiology to ManagementCaitlin A Kearney, Ciara A Maguire, Vikash S Oza, et al.
American Journal of Clinical Dermatology|September 19, 2025
Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD RegistryAmy S Paller, Danielle Marcoux, Michele Ramien, et al.
American Journal of Clinical Dermatology|July 29, 2025
Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial ResultsKim A Papp, Mark G Lebwohl, Lluís Puig, et al.
Pageof 158